ResultsIQ

ResultsIQ › Latest results › Sukhjit Starch & Chemicals Limited

Sukhjit Starch & Chemicals Limited Q2 FY26 earnings call summary

NSE: SUKHJITS · BSE: 524542

Earnings call of 13 Nov 2025, summarised by AI from the filing.

Sukhjit Q2 FY26 revenue ₹312.68 cr and net profit ₹4.07 cr; management expects sequential improvement in H2 FY26.

Key takeaways

  1. Guidance Management expects sequential improvement in operating performance in H2 FY26 and margin improvement from here on.
  2. Change Maize farmyard price fell to between 19 and 20 from between 22 and 23 in Q1.
  3. Driver Maize prices softening on better Kharif arrivals and government policies encouraging higher cultivation.

Original filing on BSE

Sukhjit Starch & Chemicals Limited Q1 FY27 results

As filed: Revenue ₹396 cr (+7% year on year), EBITDA ₹30.2 cr (+59% year on year), PAT ₹12.2 cr (+143% year on year), EBITDA margin 7.6% (+247 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹402 cr (+12% year on year), EBITDA ₹25.8 cr (+52% year on year), PAT ₹14.6 cr (+300% year on year), EBITDA margin 6.4% (+171 bps). Score 85 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 171 bps year on year. Other income 44% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −12.6% in 29 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹347 cr (−7% year on year), EBITDA ₹19.5 cr (−33% year on year), PAT ₹3.1 cr (−72% year on year), EBITDA margin 5.6% (−211 bps). Score 19 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 211 bps year on year. Other income 41% of PBT. Profit fell 22% from last quarter. Share price after the results: −8.9% in 29 days (Nifty 500: −10.1%).
  • Q2 FY26: Revenue ₹315 cr (−14% year on year), EBITDA ₹18.0 cr (−44% year on year), PAT ₹4.0 cr (−69% year on year), EBITDA margin 5.7% (−298 bps). Score 5 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 298 bps year on year. Other income 100% of PBT. Tax rate 0%. Revenue fell 15% from last quarter. Share price after the results: −4.0% in 29 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹369 cr (−7% year on year), EBITDA ₹19.0 cr (−42% year on year), PAT ₹5.0 cr (−64% year on year), EBITDA margin 5.2% (−321 bps). Score 12 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 321 bps year on year. Other income 50% of PBT. Share price after the results: +2.7% in 30 days (Nifty 500: +2.1%).
  • Q4 FY25: Revenue ₹360 cr (−3% year on year), EBITDA ₹17.0 cr (−48% year on year), PAT ₹3.0 cr (−75% year on year), EBITDA margin 4.7% (−420 bps). Score 3 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 420 bps year on year. Other income 75% of PBT. Tax rate 50%. Revenue fell 4% from last quarter. Share price after the results: −13.3% in 28 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹375 cr (+4% year on year), EBITDA ₹29.0 cr (−19% year on year), PAT ₹11.0 cr (−31% year on year), EBITDA margin 7.7% (−224 bps). Score 29 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 224 bps year on year. Profit fell 15% from last quarter.
  • Q2 FY25: Revenue ₹368 cr (+15% year on year), EBITDA ₹32.0 cr (+7% year on year), PAT ₹13.0 cr (+18% year on year), EBITDA margin 8.7% (−65 bps). Score 63 of 100, In line with trend. Revenue, EBITDA and profit growth were above the company's own trend. EBITDA margin fell 65 bps year on year. Revenue fell 7% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Sukhjit Starch & Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.